Literature DB >> 27472157

HEALTH TECHNOLOGY ASSESSMENT, DELIBERATIVE PROCESS, AND ETHICALLY CONTESTED ISSUES.

Norman Daniels1, Gert Jan van der Wilt2.   

Abstract

Healthcare technology assessment (HTA) aims to support decisions as to which technologies should be used in which situations to optimize value. Because such decisions will create winners and losers, they are bound to be controversial. HTA, then, faces a dilemma: should it stay away from such controversies, remaining a source of incomplete advice and risking an important kind of marginalization, or should it enter the controversy? The question is a challenging one, because we lack agreement on principles that are fine grained enough to tell us what choices we should make. In this study, we will argue that HTA should take a stand on ethical issues raised by the technology that is being investigated. To do so, we propose adding a form of procedural justice to HTA to arrive at decisions that the public can regard as legitimate and fair. A fair process involves deliberation about the reasons, evidence, and rationales that are considered relevant to meeting population-health needs fairly. One important way to make sure that there is real deliberation about relevant reasons is to include a range of stakeholders in the deliberative process. To illustrate how such deliberation might work, we use the case of cochlear implants for deaf children.

Entities:  

Keywords:  Accountability; Cochlear implants; Deliberative democracy; Fairness; Priority setting; Wide reflective equilibrium

Mesh:

Year:  2016        PMID: 27472157     DOI: 10.1017/S0266462316000155

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  7 in total

1.  Ethics in HTA: Examining the "Need for Expansion".

Authors:  Payam Abrishami; Wija Oortwijn; Bjørn Hofmann
Journal:  Int J Health Policy Manag       Date:  2017-10-01

2.  Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study.

Authors:  Monika Wagner; Dima Samaha; Roman Casciano; Matthew Brougham; Payam Abrishami; Charles Petrie; Bernard Avouac; Lorenzo Mantovani; Antonio Sarría-Santamera; Paul Kind; Michael Schlander; Michele Tringali
Journal:  Int J Health Policy Manag       Date:  2019-07-01

3.  Stakeholder Participation for Legitimate Priority Setting: A Checklist.

Authors:  Maarten P M Jansen; Rob Baltussen; Kristine Bærøe
Journal:  Int J Health Policy Manag       Date:  2018-11-01

4.  Integrating health technology assessment and the right to health: a qualitative content analysis of procedural values in South African judicial decisions.

Authors:  Michael J DiStefano; Safura Abdool Karim; Carleigh B Krubiner
Journal:  Health Policy Plan       Date:  2022-05-12       Impact factor: 3.547

Review 5.  Systematic literature review on the implicit factors influencing the HTA deliberative process in Europe.

Authors:  Clara Monleón; Hans-Martin Späth; Carlos Crespo; Claude Dussart; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2022-06-28

6.  Evaluating facts and facting evaluations: On the fact-value relationship in HTA.

Authors:  Bjørn Hofmann; Ken Bond; Lars Sandman
Journal:  J Eval Clin Pract       Date:  2018-04-03       Impact factor: 2.431

7.  Neonatology in Austria: ethics to improve practice.

Authors:  Michal Stanak
Journal:  Med Health Care Philos       Date:  2020-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.